BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 11579601)

  • 1. [A case of transitional cell carcinoma of the urinary bladder with high serum level of CEA and CA19-9].
    Inai H; Shimazui T; Yamamoto T; Yamauchi A; Uchida K; Takeshima H; Akaza H
    Hinyokika Kiyo; 2001 Aug; 47(8):583-6. PubMed ID: 11579601
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [A case of CEA and CA19-9 producing recurrent transitional cell carcinoma in an Indiana pouch after total cystectomy].
    Miyoshi Y; Asakura T; Matsuzaki J; Fukuda M; Satomi Y; Akabane H
    Hinyokika Kiyo; 1996 Dec; 42(12):961-4. PubMed ID: 9013232
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [A case of transitional cell carcinoma of renal pelvis with extremely high serum levels of CA19-9 and CEA].
    Sugaya Y; Ochi M; Hashimoto S; Muraki J; Morita T; Kobayashi Y; Nakamura S; Tokue A
    Hinyokika Kiyo; 1997 Jul; 43(7):495-9. PubMed ID: 9282296
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [A case of CA19-9 producing transitional cell carcinoma of the ureter].
    Yamamoto H; Ueda Y; Maruyama T; Kondou N; Nojima M; Takiuchi H; Mori Y; Shima H; Kubota A
    Hinyokika Kiyo; 2003 Sep; 49(9):543-5. PubMed ID: 14598694
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical usefulness of CEA, CA19-9, and CYFRA 21-1 as tumor markers for urothelial bladder carcinoma.
    Washino S; Hirai M; Matsuzaki A; Kobayashi Y
    Urol Int; 2011; 87(4):420-8. PubMed ID: 22041857
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [A case of CEA-producing renal pelvic and ureteral cancer].
    Abe T; Konari S; Ogata M; Komatsu S; Satoh T
    Hinyokika Kiyo; 2003 Feb; 49(2):75-9. PubMed ID: 12696186
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CA19.9 and CEA in transitional cell carcinoma of the bladder: serological and immunohistochemical findings.
    Hegele A; Mecklenburg V; Varga Z; Olbert P; Hofmann R; Barth P
    Anticancer Res; 2010 Dec; 30(12):5195-200. PubMed ID: 21187512
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [A case of transitional cell carcinoma of the renal pelvis with adenocarcinoma producing CEA and CA19-9].
    Matsuoka Y; Ishimaru H; Arai G; Aida J; Okada Y; Ito Y
    Hinyokika Kiyo; 2004 Sep; 50(9):637-40. PubMed ID: 15518131
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Superficial urothelial carcinoma of ureter with elevated serum CA19-9 and CEA].
    Kato S; Yasuda M; Nakano M; Ehara H; Ishihara T; Deguchi T; Sakata Y; Mori H; Shimokawa K
    Hinyokika Kiyo; 2004 Feb; 50(2):99-102. PubMed ID: 15101165
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Adenocarcinoma of the bladder producing carcinoembryonic antigen and carbohydrate antigen 19-9: report of a case].
    Iwaki H; Omatsu S; Konishi T; Moritani S
    Hinyokika Kiyo; 1997 May; 43(5):355-8. PubMed ID: 9208321
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The clinical value of serum CEA, CA19-9, and CA242 in the diagnosis and prognosis of pancreatic cancer.
    Ni XG; Bai XF; Mao YL; Shao YF; Wu JX; Shan Y; Wang CF; Wang J; Tian YT; Liu Q; Xu DK; Zhao P
    Eur J Surg Oncol; 2005 Mar; 31(2):164-9. PubMed ID: 15698733
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Usefulness of preoperative assay CEA and CA 19-9 in colorectal cancer patients].
    Grotowski M; MaruszyƄski M; Piechota W
    Pol Merkur Lekarski; 2001 Dec; 11(66):476-9. PubMed ID: 11899841
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnostic value of serum tumor markers in asymptomatic individuals.
    Eleftheriadis N; Papaloukas C; Pistevou-Gompaki K
    J BUON; 2009; 14(4):707-10. PubMed ID: 20148467
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The use of tumor markers as predictors of prognosis in gastric cancer.
    Mihmanli M; Dilege E; Demir U; Coskun H; Eroglu T; Uysalol MD
    Hepatogastroenterology; 2004; 51(59):1544-7. PubMed ID: 15362797
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Ureteral cancer producing carbohydrate antigen 19-9: report of a case].
    Segawa N; Yamamoto K; Watsuji T; Suzuki T; Ueda H; Katsuoka Y
    Hinyokika Kiyo; 1997 Sep; 43(9):665-8. PubMed ID: 9365848
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Recrudescence of prostate cancer with low serum level of PSA and high serum level of CEA and CA19-9: a case report].
    Yokoyama S; Fukuhara S; Imazu T; Hara T; Yamaguchi S; Adachi S
    Hinyokika Kiyo; 2007 Jul; 53(7):485-7. PubMed ID: 17702183
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Primary paraganglioma of the urinary bladder with high serum CA19-9 level: a case report].
    Nakayama Y; Asazuma A; Shirahase T; Soeda A; Hashimoto K; Oishi K
    Hinyokika Kiyo; 2000 Feb; 46(2):131-5. PubMed ID: 10769805
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Prostate cancer with high serum level of CEA and CA19-9: a case report].
    Momma T; Kimura S; Saito S; Onoda N
    Hinyokika Kiyo; 1998 Mar; 44(3):187-91. PubMed ID: 9589883
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Is it reasonable to add preoperative serum level of CEA and CA19-9 to staging for colorectal cancer?
    Chen CC; Yang SH; Lin JK; Lin TC; Chen WS; Jiang JK; Wang HS; Chang SC
    J Surg Res; 2005 Apr; 124(2):169-74. PubMed ID: 15820244
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Detection and clinical study of serum tumor markers in patients with colorectal cancer].
    Zhao XW; Jiang B; Han CZ; Jing JX
    Zhonghua Zhong Liu Za Zhi; 2005 May; 27(5):286-8. PubMed ID: 15996321
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.